Aras Toker

1.1k total citations
21 papers, 620 citations indexed

About

Aras Toker is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Aras Toker has authored 21 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 7 papers in Oncology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Aras Toker's work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (10 papers). Aras Toker is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (11 papers) and T-cell and B-cell Immunology (10 papers). Aras Toker collaborates with scholars based in Germany, Netherlands and United States. Aras Toker's co-authors include Jochen Huehn, Pamela S. Ohashi, Takahisa Miyao, Shohei Hori, Clare Y. Slaney, B. Thomas Bäckström, Stefan Floess, Garima Garg, Zhe Qi Liu and Robert Geffers and has published in prestigious journals such as Science, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Aras Toker

17 papers receiving 612 citations

Peers

Aras Toker
Douglas E. Kline United States
Te-Chia Wu United States
Ioannis Tassiulas United States
Travis J. Friesen United States
Rita J. Luther United States
Billur Akkaya United States
Marcella Flores United States
Alexander P. R. Bally United States
Douglas E. Kline United States
Aras Toker
Citations per year, relative to Aras Toker Aras Toker (= 1×) peers Douglas E. Kline

Countries citing papers authored by Aras Toker

Since Specialization
Citations

This map shows the geographic impact of Aras Toker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aras Toker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aras Toker more than expected).

Fields of papers citing papers by Aras Toker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aras Toker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aras Toker. The network helps show where Aras Toker may publish in the future.

Co-authorship network of co-authors of Aras Toker

This figure shows the co-authorship network connecting the top 25 collaborators of Aras Toker. A scholar is included among the top collaborators of Aras Toker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aras Toker. Aras Toker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Muik, Alexander, Jasmin Quandt, Bonny Gaby Lui, et al.. (2024). Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1. Cell Reports. 43(8). 114567–114567.
2.
Imle, Andrea, Andreea Ioan‐Facsinay, Maren Köhne, et al.. (2024). 731 The combination of an EpCAMx4–1BB bispecific antibody with PD-1 blockade potentiates single-agent effects on T-cell functions and enhances antitumor activity in preclinical studies. Regular and Young Investigator Award Abstracts. A833–A833.
3.
Ioan‐Facsinay, Andreea, Andrea Imle, Lars Guelen, et al.. (2023). 1072P DuoBody-EpCAMx4-1BB mediates conditional T cell co-stimulation and promotes antitumor activity in preclinical models. Annals of Oncology. 34. S645–S646.
4.
Muik, Alexander, Bonny Gaby Lui, Maren Bacher, et al.. (2022). Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5. Science Immunology. 7(77). eade2283–eade2283. 45 indexed citations
5.
Imle, Andrea, Aras Toker, Kristin Strumane, et al.. (2022). 1070 HexaBody-CD27 enhances T-cell activation, proliferation, cytokine secretion and cytotoxic activity independently of Fc gamma receptor-mediated crosslinking. Regular and Young Investigator Award Abstracts. A1112–A1112. 1 indexed citations
6.
Liu, Ming, Jinyi Zhang, Benjamin D. Pinder, et al.. (2021). WAVE2 suppresses mTOR activation to maintain T cell homeostasis and prevent autoimmunity. Science. 371(6536). 33 indexed citations
7.
Muik, Alexander, Rachelle Kosoff, Friederike Gieseke, et al.. (2021). Abstract 1846: DuoBody-CD40×4-1BB (GEN1042) induces dendritic-cell maturation and enhances T-cell activation and effector functions in vitro by conditional CD40 and 4-1BB agonist activity. Cancer Research. 81(13_Supplement). 1846–1846. 2 indexed citations
9.
Han, SeongJun, Aras Toker, Zhe Qi Liu, & Pamela S. Ohashi. (2019). Turning the Tide Against Regulatory T Cells. Frontiers in Oncology. 9. 279–279. 47 indexed citations
10.
Toker, Aras, Yohko Kitagawa, Naganari Ohkura, et al.. (2019). Dynamic Imprinting of the Treg Cell-Specific Epigenetic Signature in Developing Thymic Regulatory T Cells. Frontiers in Immunology. 10. 2382–2382. 23 indexed citations
11.
MacGregor, Heather, Carlos R. Garcia-Batres, Azin Sayad, et al.. (2019). Tumor cell expression of B7-H4 correlates with higher frequencies of tumor-infiltrating APCs and higher CXCL17 expression in human epithelial ovarian cancer. OncoImmunology. 8(12). e1665460–e1665460. 30 indexed citations
12.
Toker, Aras, Linh T. Nguyen, Simone C. Stone, et al.. (2018). Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from that in Melanoma. Clinical Cancer Research. 24(22). 5685–5696. 85 indexed citations
13.
Garg, Garima, Eirini Nikolouli, Matthias Hardtke‐Wolenski, et al.. (2017). Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells. Oncotarget. 8(22). 35542–35557. 19 indexed citations
14.
Milanez‐Almeida, Pedro, Michael Meyer‐Hermann, Aras Toker, Sahamoddin Khailaie, & Jochen Huehn. (2014). Foxp3+ regulatory T‐cell homeostasis quantitatively differs in murine peripheral lymph nodes and spleen. European Journal of Immunology. 45(1). 153–166. 10 indexed citations
15.
Slaney, Clare Y., Aras Toker, John D. Fraser, Jacquie L. Harper, & B. Thomas Bäckström. (2013). A modified superantigen rescues Ly6GCD11b+blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE. Autoimmunity. 46(4). 269–278. 4 indexed citations
16.
Toker, Aras, Dirk Engelbert, Garima Garg, et al.. (2013). Active Demethylation of the Foxp3 Locus Leads to the Generation of Stable Regulatory T Cells within the Thymus. The Journal of Immunology. 190(7). 3180–3188. 202 indexed citations
17.
Toker, Aras, et al.. (2012). Maximizing Return on Investment for the University of San Francisco Athletic Department Through Sponsorship. USF Scholarship Repository (University of San Francisco).
18.
Toker, Aras, Clare Y. Slaney, B. Thomas Bäckström, & Justin Harper. (2011). Glatiramer Acetate Treatment Directly Targets CD11b+Ly6G Monocytes and Enhances the Suppression of Autoreactive T cells in Experimental Autoimmune Encephalomyelitis. Scandinavian Journal of Immunology. 74(3). 235–243. 27 indexed citations
19.
Toker, Aras & Jochen Huehn. (2011). To Be or Not to Be a T reg Cell: Lineage Decisions Controlled by Epigenetic Mechanisms. Science Signaling. 4(158). pe4–pe4. 29 indexed citations
20.
Slaney, Clare Y., et al.. (2010). Naïve blood monocytes suppress T‐cell function. A possible mechanism for protection from autoimmunity. Immunology and Cell Biology. 89(1). 7–13. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026